ENvue Medical, Inc. Proceeds from Stock Options Exercised
ENvue Medical, Inc. (FEED) reported Proceeds from Stock Options Exercised of $102.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-17
- ENvue Medical, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $0.00.
- ENvue Medical, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $0.00.
- ENvue Medical, Inc. proceeds from stock options exercised for the quarter ending 2024-12-31 was $0.00.
- ENvue Medical, Inc. proceeds from stock options exercised for the quarter ending 2024-09-30 was -$27.00K.
- ENvue Medical, Inc. proceeds from stock options exercised for fiscal 2025 was $102.00K, a 10100.00% increase from fiscal 2024.
- ENvue Medical, Inc. proceeds from stock options exercised for fiscal 2024 was $1.00K, a 85.71% decline from fiscal 2023.
- ENvue Medical, Inc. proceeds from stock options exercised for fiscal 2023 was $7.00K, a 250.00% increase from fiscal 2022.
- ENvue Medical, Inc. proceeds from stock options exercised for fiscal 2022 was $2.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | $102.00K 10-K · filed 2026-04-15 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $102.00K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $102.00K 10-Q · filed 2026-08-17 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$27.00K derived: sum of 2 quarters · filed 2026-04-15 | $1.00K 10-K · filed 2026-04-15 | |
| 2024-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.00K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $28.00K 10-Q · filed 2025-08-19 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $7.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $7.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $7.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $2.00K 10-K · filed 2024-04-08 | |||
| 2019-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $62.00K derived: sum of 2 quarters · filed 2021-04-15 | $66.00K 10-K · filed 2021-04-15 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $4.00K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $4.00K 10-Q/A · filed 2020-08-24 | |||
| 2018-12-31 | $3.00K 10-K · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |